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Background: Virtual Touch tissue quantification (VTTQ) is a promising new technology that quantitatively
determines the stiffness of tissue. However, the clinical impact of this device on the assessment of breast cancer
is unclear.
Methods: This study aimed to review the ultrasound records of patients with breast lesions where VTTQ was used
to assess 123 normal breast tissues, 18 benign tumors, and 117 histopathologically confirmed breast cancers in a
total of 129 patients. To determine the VTTQ value, a 5 × 5 mm region of interest was placed in the center of the
area of interest, and the target lesion was measured at least three times by VTTQ.
Results: Seventy-six percent of the malignant lesions could not be assessed using VTTQ. Among the malignant
lesions, ductal carcinomas in situ (DCIS) and invasive breast cancers smaller than 1.6 cm tended to be ‘measurable.’
Only 17 and 1% of benign breast lesions and areas of normal breast tissue, respectively, were considered to be
‘unmeasurable’ (P < 0.001).
Conclusions: A breast lesion that could not be quantitatively assessed by VTTQ was suspicious for malignancy. By
contrast, DCIS lesions and small invasive breast cancers tended to be ‘measurable.’ These findings indicate that
VTTQ may be a useful application for assessing breast tumors.
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Ultrasonography is an essential diagnostic tool for breast
neoplasms. B-mode ultrasound (US) imaging is a conven-
tional, but especially important modality for clinical practice
because of its high sensitivity [1]. However, B-mode im-
aging is limited because of its relatively low specificity [1].
Therefore, advanced US technologies, including Doppler
ultrasonography [2] and contrast-enhanced ultrasonog-
raphy [3], have been developed, and provide some diagnos-
tic advantages.
Breast ultrasound elastography was introduced into
clinical practice in order to support US diagnostic im-
aging. Manual compression of an area of interest using* Correspondence: ktada-tky@umin.ac.jp
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unless otherwise stated.an US probe produces strain [4]. Assessment of the level
of strain allows estimation of the hardness of a tissue, a
characteristic that can be applied to the diagnosis of a
breast lesion. A meta-analysis comparing the diagnostic
performance of breast US elastography with B-mode im-
aging found that elastography had greater specificity [1].
However, manual compression must be performed prop-
erly, which requires training of the ultrasonographer.
Furthermore, the stiffness of the lesion must be evalu-
ated relative to the surrounding normal breast tissue [4].
A new type of elastography, Virtual Touch tissue quantifi-
cation (VTTQ), which was recently introduced, quantifies
the stiffness of breast tissue without using mechanical com-
pression [5]. Acoustic radiation force impulse (ARFI) tech-
nology induces the mechanical excitation of tissue by means
of localized impulsive radiation force, thereby propagatinghis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lated. The velocity of the propagated shear wave is related
to the stiffness of the tissue. Shear wave speed generally in-
creases with increasing tissue stiffness. Therefore, tissue
stiffness can be easily quantified from the velocity of the
shear wave.
Although this new technology appears to be a promising
diagnostic modality, its clinical applicability to breast le-
sions is unclear. The finding of increased stiffness is
thought to be associated with malignant breast tissue. How-
ever, previous studies have failed to confirm this hypothesis
because VTTQ systems frequently failed to provide a stiff-
ness value; in other words the VTTQ system displayed the
reading ‘X.XX m/s.’ Therefore, it is important to identify
the characteristics of breast lesions that allow VTTQ
assessment.
In this study, we retrospectively investigated the VTTQ
assessments of breast tissue, including normal tissue and
benign and malignant lesions to determine which charac-
teristics of breast tissue and breast lesions are associated
with successful VTTQ assessment.
Methods
VTTQ measurement
VTTQ was performed using the ACUSON S2000 ultra-
sound system equipped with the 9 L4 transducer (Siemens
Medical Solutions, Mountain View, CA), according to a
modification of the method published by Tozaki et al. [6].
Briefly, a 5 × 5 mm region of interest (ROI) was placed in
the center of the area of interest (Figure 1a). The target le-
sion was measured at least three times. If every measure-
ment was obtained successfully, the target lesion was
classified as ‘measurable.’ The mean measurement was the
final value for stiffness. If a measurement value was dis-
played as ‘X.XX m/s’ at least once, the lesion was classified
as ‘unmeasurable’ (Figure 1b). Normal breast tissue adja-
cent to the lesion was tested in the same way. In a breast
with several cancerous nodules, the largest and the second
largest nodule were measured. Two operators (K.T. and
K.N.), who each had more than 10 years of experience
performing breast US imaging, performed these studies.
Patients
According to our ultrasound registry, 1,033 patients under-
went breast ultrasonography via the ACUSON S2000 ultra-
sound system from May 2011 to March 2013. Of these
patients, 144 underwent VTTQ elastography. Of these pa-
tients, 112 were found to have 118 malignant lesions and 19
to have 19 benign lesions. Data from cases meeting the fol-
lowing criteria were extracted for analysis: 1) VTTQ assess-
ment had been performed using the methods described in
the previous section, 2) histopathologically confirmed breast
cancer lesion, or 3) histopathologically or cytologically con-
firmed benign breast lesion. This study finally included 111patients with 117 malignant lesions and 18 patients with 18
benign lesions. All the study patients were female. The mean
ages of patients with breast cancer and benign lesions were
56.1 years (range 28 to 85 years) and 46.4 years (range 24 to
77 years), respectively.
Statistical analysis
The chi-square test was used for categorical data. For
numerical data, the Kruskal-Wallis test and Mann-
Whitney test were used to compare multiple and two
groups, respectively. Receiver operating characteristic
(ROC) analysis was used to evaluate lesion size for
measurability. P ≤ 0.05 was considered significant. IBM
SPSS Statistics Desktop version 20 was used for analysis.
Permission to perform this retrospective study was ob-
tained from the ethical board of our institution.
Results
A total of 135 areas of normal breast tissue in 129 patients
were measured using VTTQ, and 123 areas among them
were analyzed in this study. Twelve areas were excluded
because they were tested less than three times. Further-
more, a total of 19 benign breast tumors were measured,
and 18 of them were analyzed in this study. One benign
mass was excluded because it was tested less than three
times. There were 8 fibroadenomas, 2 cases of mastopa-
thy, and 1 case each of inflammation, breast hamartoma,
and breast cyst. For the remaining 5 cases, a fine needle
aspiration biopsy was negative for malignancy. A total of
118 breast cancer lesions were measured. One mass was
excluded because it was tested less than three times. The
117 malignant lesions that were analyzed included 13
cases of ductal carcinoma in situ (DCIS) and 104 cases of
invasive carcinoma.
Table 1 shows the distribution of measurable and unmeas-
urable ROIs among the tested tissues of normal breast, be-
nign breast tumors, and malignant lesions. Of the tested
ROIs, 76% of malignant lesions, 17% of benign breast le-
sions, and 1% of normal breast tissues were unmeasureable
(P < 0.001).
Table 2 shows the frequencies of unmeasurable DCIS
and invasive breast cancer lesions. More cases of inva-
sive breast cancers were unmeasurable than cases of
DCIS (P = 0.002).
Figure 2 shows the relationship between tumor size
and measurability for lesions of invasive breast cancer.
Smaller lesions of invasive breast cancer were more
likely to be measurable (Mann-Whitney test, P = 0.002).
Figure 3 shows the ROC curve of lesion size and meas-
urability. The Youden index was 1.6 cm, which was the
estimate for the cutoff value for the size of tumors as-
sessable using VTTQ.
Figure 4 shows the distribution of mean VTTQ values
of measureable normal breast tissues, benign lesions,
ab
Figure 1 Typical Virtual Touch tissue quantification (VTTQ) images with results. During real-time ultrasonography, a 5 × 5-mm region of interest is placed
on the area of interest. When VTTQ is activated, the display is frozen and the calculated VTTQ value is displayed (1a). When VVTQ is unsuccessful, ‘X.XXm/s’
is displayed (1b).
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creased from normal to benign to malignant lesions.
Nonparametric analysis found a significant difference
between the three types of tissues measured (P < 0.001).
However, the difference between benign and malignant
lesions was not significant (P = 0.534).Discussion
We investigated the impact of VTTQ on breast imaging,
demonstrating that this new technology has some value.
An advantage of our study is that our measurement
methodology was easy to perform. That is to say, the ROI
was placed in the center of the area of interest, three
Table 1 The proportion of lesions that were
‘unmeasurable’ according to normal, benign, and
malignant regions of interest
Unmeasurable Measurable
Normal Breast Tissue 1 (1%) 122 123
Benign Lesion 3 (17%) 15 18
Malignant Lesion 89 (76%) 28 117
P < 0.001
The percentages in parentheses indicate the proportion of ‘unmeasurable’












Figure 2 Box-and-whisker plots of breast lesion sizes according to
whether lesions were measurable or unmeasurable by Virtual Touch tissue
quantification. Nonparametric analysis found a significant difference in the
sizes of measureable versus unmeasureable lesions. The horizontal line in
the box indicates the median size of the samples. The upper and lower
sides of the box represent the 75th and 25th percentiles, respectively. The
upper and lower sides of the whiskers represent the 90th and 10th
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mean of three successful measurements, and lesions shown
as ‘X.XX m/s’ at least once were considered to be unmeas-
urable. The value for shear wave velocity is often displayed
as ‘X.XX m/s,’ and that occurs if the tissue in the ROI is het-
erogeneous, the amplitude of the shear wave is low, the
noise-to-signal ratio is high, or the velocity of the shear
wave is extremely high [7,8]. Suggestions for managing ‘X.
XX m/s’ readings vary and include the following: perform
repeated measurements (up to 23) [9], place the ROI on
the margin of the area of interest [6], and substitute
9.10 m/s for ‘X.XX m/s’ [10,11]. The authors of these stud-
ies paid particular attention to quantity and were reluctant
to accept measurement failure. Because we accepted the
possibility of measurement failure for malignant lesions, we
used a simple protocol that we believe will be easy to repro-
duce at every institution.
Our results indicate that a breast lesion that could not
be quantitatively assessed by VTTQ was suspicious for
malignancy. Seventy-six percent of malignant lesions
were characterized as unmeasurable, which was a signifi-
cantly higher rate than seen for benign lesions or normal
tissues (P < 0.001). Furthermore, the high rate was simi-
lar to rates observed by other studies [6,10]. Although
an unmeasurable lesion cannot definitively be deter-
mined to be benign or malignant, our finding is very
useful for clinical practice.
Another advantage of our study was that the small inva-
sive breast cancers and lesions of DCIS were associated
with successful VTTQ measurement. We can reveal these
findings because our investigation included more than
100 cases of breast cancer. These findings are importantTable 2 The proportion of ‘unmeasurable’ regions of
interest that were invasive cancer or DCIS lesions
Unmeasurable Measurable
Invasive cancer 84 (81%) 20 104
DCIS 5 (39%) 8 13
P = 0.002
The percentages in parentheses indicate the proportion of ‘unmeasurable’
invasive cancer or DCIS lesions. Chi-square test was used for statistical analysis.
DCIS: ductal carcinoma in situ.for successful VTTQ measurements of breast lesions less
than 1.6 cm or DCIS lesions.
The VTTQ technology has several advantages for
breast imaging. First, this technology is easy to use and
noninvasive. Second, the measuring device does not0
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Figure 3 Receiver operating characteristic curve of breast lesion sizes
according to whether lesions were measurable or unmeasurable by













Figure 4 Box-and-whisker plot of Virtual Touch tissue quantification
of the region of interest in normal breast, benign breast lesions, and
malignant lesions. There was a significant difference between the
velocity of the shear waves produced by these three types of lesions
according to nonparametric analysis. However, there was no significant
difference between benign and malignant lesions. The horizontal line
in the box indicates the median of the samples. The upper and lower
sides of the box represent the 75th and 25th percentiles, respectively.
The upper and lower sides of the whiskers represent the 90th and
10th percentiles, respectively. ‘M’ is the mean value of these samples.
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needed for ultrasonographers. Last, this type of elasto-
graphy can produce absolute values for stiffness. These
features make this technology highly advantageous com-
pared to the current breast imaging systems.
However, for the accurate evaluation of breast tumors
by VTTQ elastography, additional studies of patients with
various breast lesions, including mucinous tumors, nec-
rotic tumors, intracystic tumors, and microcalcification-
containing lesions are needed. The technology used for
measurement also needs improvement. As mentioned
previously, ‘X.XX m/s’ is displayed for a variety of reasons
[6,9-11]. The reasons why malignant lesions are unmeas-
urable must be clarified for clinicians. Furthermore, our
study found that there was no significant difference in the
degree of stiffness between the measureable benign and
measureable malignant lesions. Although we believe
that the small number of measureable cases could have
accounted for our result, further investigation is needed
to resolve this issue.Conclusions
A breast lesion that could not be quantitatively assessed
by VTTQ was suspicious for malignancy. By contrast, le-
sions of DCIS and small invasive breast cancers tended to
be ‘measurable.’ These findings indicate that VTTQ may
be a useful application for assessing breast tumors.Abbreviations
DCIS: ductal carcinoma in situ; ROC curve: receiver operating characteristic
curve; US: ultrasound; VTTQ: Virtual Touch tissue quantification.
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